| Value | ₹2.01 Cr |
|---|---|
| Execution period | Vesting starts after 1 year; exercise up to 5 years |
NSE filing, NSE: CENTRUM. Summary written from the filing by ALFA Finder's alert engine.
Centrum Capital Ltd: key numbers
- Share price
- ₹19.70
- Market cap
- ₹982.1 Cr
- Revenue (annual)
- ₹3,763 Cr
- Net profit (annual)
- ₹-138.2 Cr
- P/E (TTM)
- -3.8×Sector 19.7×
- Promoter holding
- 40.86%+1.42% QoQ
- FII holding
- 1.21%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Centrum Capital Ltd
All →Centrum Capital Other Announcement
Centrum Capital submitted its Monitoring Agency Report on utilisation of preferential warrant proceeds for the quarter ended 30 September 2026. The report, issued by Brickwork Ratings, shows no deviation from objects.
Centrum Capital Convertible Warrants
JBCG Advisory Services exercised 1.17 crore Centrum Capital warrants on October 8, 2026. This raised its promoter-group holding from 11.81% to 13.88% of total share capital.
Centrum Capital Other Announcement
Centrum Capital Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Centrum Capital Share Pledge
Business Match Services disclosed creation of a pledge over Centrum Capital shares under SAST Reg 31(1). The encumbrance secures loans from MINGUL, 5 LOGAIN and STC Finance.
Centrum Capital Capital Structure Change
Centrum Capital allotted 116.88 lakh equity shares at Rs. 28.52 each via warrant exercise. The allotment raises approximately Rs. 33.33 Crore in fresh capital.
- Value
- ₹33.33 Cr
Centrum Capital Capital Structure Change
Centrum Capital allotted 1.17 Crore shares at ₹28.52 to promoter JBCG upon warrant conversion. Balance ₹25 Crore received; promoter stake rises to 40.86%.
- Value
- ₹25.00 Cr
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.